Alteration of Neuropilin-1 and Heparan Sulfate Interaction Impairs Murine B16 Tumor Growth.

Saved in:
Bibliographic Details
Title: Alteration of Neuropilin-1 and Heparan Sulfate Interaction Impairs Murine B16 Tumor Growth.
Authors: Painter CD; Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, California 92093, United States.; Glycobiology Research and Training Center, University of California, San Diego, La Jolla, California 92093, United States., Sankaranarayanan NV; Department of Medicinal Chemistry, Virginia Commonwealth University, Richmond, Virginia 23298, United States.; Institute for Structural Biology, Drug Discovery and Development, Virginia Commonwealth University, Richmond, Virginia 23219, United States., Nagarajan B; Department of Medicinal Chemistry, Virginia Commonwealth University, Richmond, Virginia 23298, United States.; Institute for Structural Biology, Drug Discovery and Development, Virginia Commonwealth University, Richmond, Virginia 23219, United States., Mandel Clausen T; Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, California 92093, United States.; Glycobiology Research and Training Center, University of California, San Diego, La Jolla, California 92093, United States., West AMV; Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, California 92093, United States., Setiawan NJ; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington 98109, United States., Park J; Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, California 92093, United States., Porell RN; Glycobiology Research and Training Center, University of California, San Diego, La Jolla, California 92093, United States.; Department of Chemistry and Biochemistry, University of California, San Diego, La Jolla, California 92093, United States., Bartels PL; Glycobiology Research and Training Center, University of California, San Diego, La Jolla, California 92093, United States.; Department of Chemistry and Biochemistry, University of California, San Diego, La Jolla, California 92093, United States., Sandoval DR; Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, California 92093, United States.; Glycobiology Research and Training Center, University of California, San Diego, La Jolla, California 92093, United States., Vasquez GJ; Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, California 92093, United States., Chute JP; Samuel Oschin Cancer Center, Cedars Sinai Medical Center, Los Angeles, California 90048, United States.; Division of Hematology & Cellular Therapy, Cedars Sinai Medical Center, Los Angeles, California 90048, United States.; Regenerative Medicine Institute, Cedars Sinai Medical Center, Los Angeles, California 90048, United States., Godula K; Glycobiology Research and Training Center, University of California, San Diego, La Jolla, California 92093, United States.; Department of Chemistry and Biochemistry, University of California, San Diego, La Jolla, California 92093, United States., Vander Kooi CW; Department of Biochemistry and Molecular Biology, University of Florida, Gainesville, Florida 32610, United States., Gordts PLSM; Glycobiology Research and Training Center, University of California, San Diego, La Jolla, California 92093, United States.; Department of Medicine, University of California, San Diego, La Jolla, California 92093, United States., Corbett KD; Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, California 92093, United States.; Department of Molecular Biology, University of California, San Diego, La Jolla, California 92093, United States., Termini CM; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington 98109, United States., Desai UR; Department of Medicinal Chemistry, Virginia Commonwealth University, Richmond, Virginia 23298, United States.; Institute for Structural Biology, Drug Discovery and Development, Virginia Commonwealth University, Richmond, Virginia 23219, United States., Esko JD; Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, California 92093, United States.; Glycobiology Research and Training Center, University of California, San Diego, La Jolla, California 92093, United States.
Source: ACS chemical biology [ACS Chem Biol] 2024 Aug 16; Vol. 19 (8), pp. 1820-1835. Date of Electronic Publication: 2024 Aug 04.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Journal Info: Publisher: American Chemical Society Country of Publication: United States NLM ID: 101282906 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1554-8937 (Electronic) Linking ISSN: 15548929 NLM ISO Abbreviation: ACS Chem Biol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1554-8937
DOI:10.1021/acschembio.4c00389